A consortium of buyers has made a $4.59 billion takeover bid for China Biologic, reported Reuters. The buyer group includes CITIC Capital China Partners. China Biologic is a developer of plasma-based therapies.
Buyers group makes $4.59 bln bid for China Biologic: Reuters
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.